Related Experiment Video
Updated: Jun 3, 2026
10:24
A Fluorescence-based Protocol for Preliminary Screening of Protein Synthesis Inhibitors from Natural Sources
Published on: January 27, 2026
Targeting translation dependence in cancer
Abba Malina1, Regina Cencic, Jerry Pelletier
1Department of Biochemistry, McIntyre Medical Sciences Building, McGill University, Montreal, Quebec, Canada.
Oncotarget
|March 8, 2011
Summary
Targeting cancer cell survival mechanisms is key. Researchers are developing new anti-cancer therapies by focusing on translational control, specifically targeting the eukaryotic initiation factor (eIF) 4F complex.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Therapeutics
Background:
- Selective targeting of cancer cells over normal cells remains a significant challenge in cancer therapy.
- Translational control is a promising target for anti-cancer strategies due to its regulation by key cancer signaling pathways.
- The eukaryotic initiation factor (eIF) 4F complex plays a crucial role in integrating signals to the translation machinery.
Purpose of the Study:
- To explore novel therapeutic approaches for cancer by targeting translational control.
- To investigate methods for selectively inhibiting the eukaryotic initiation factor (eIF) 4F complex in malignant cells.
Main Methods:
- Developing novel therapeutic strategies.
- Investigating the role of translational control in cancer.
- Focusing on the eukaryotic initiation factor (eIF) 4F complex as a therapeutic target.
Main Results:
- Approaches targeting the eukaryotic initiation factor (eIF) 4F complex are under development.
- This strategy aims to exploit the altered translational control in cancer cells.
- The eukaryotic initiation factor (eIF) 4F complex integrates multiple signaling inputs relevant to cancer.
Conclusions:
- Targeting translational control, specifically the eukaryotic initiation factor (eIF) 4F complex, offers a promising avenue for selective cancer therapy.
- Developing therapies that inhibit the eukaryotic initiation factor (eIF) 4F complex could lead to more effective and less toxic cancer treatments.
Related Concept Videos
01:31Translation
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
01:31Translation
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:28Leaky Scanning
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...